BBIO
BridgeBio Pharma, Inc. Common StockstockNASDAQ
Market OpenNov 16, 2026 10:48:06 AM EST
78.35USD+0.064%(+0.05)164,005
Pre-marketNov 16, 2026 8:38:30 AM EST
78.45USD+0.192%(+0.15)
BBIO Financials
In Q3 FY 2026 (ended ), BridgeBio Pharma, Inc. Common Stock (BBIO) reported revenue of $353.17M, net income of −$56.71M, operating cash flow of −$44.17M, and assets of $2.16B (filed ).
Loading financial statements…